IBBQ:NSD-Invesco Nasdaq Biotechnology ETF (USD)

ETF | Others |

Last Closing

USD 22.39

Change

-0.18 (-0.81)%

Market Cap

USD 0.03B

Volume

7.71K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
QQQM Invesco NASDAQ 100 ETF

+4.91 (+2.53%)

USD 30.45B
ACWI iShares MSCI ACWI ETF

+2.07 (+1.78%)

USD 18.45B
IBIT iShares Bitcoin Trust

+1.86 (+5.45%)

USD 17.74B
CGABL The Carlyle Group Inc. 4.625% ..

+0.15 (+0.76%)

USD 16.14B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.85 (+1.59%)

USD 15.58B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.01 (+0.02%)

USD 3.07B
IBTE iShares iBonds Dec 2024 Term T..

+0.01 (+0.04%)

USD 2.56B
IBTF iShares iBonds Dec 2025 Term T..

+0.02 (+0.06%)

USD 2.34B
NVDL GraniteShares 1.5x Long NVDA D..

+4.14 (+8.09%)

USD 2.05B
USCL iShares Climate Conscious & Tr..

+1.10 (+1.64%)

USD 2.01B

ETFs Containing IBBQ

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.28% 53% F 62% D
Dividend Return 0.20% 11% F 7% C-
Total Return 2.48% 49% F 60% D-
Trailing 12 Months  
Capital Gain 5.61% 58% F 64% D
Dividend Return 0.86% 17% F 12% F
Total Return 6.47% 52% F 61% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -2.26% 35% F 39% F
Dividend Return -2.02% 31% F 36% F
Total Return 0.25% 20% F 8% B-
Risk Return Profile  
Volatility (Standard Deviation) 10.59% 51% F 87% B+
Risk Adjusted Return -19.04% 33% F 31% F
Market Capitalization 0.03B 44% F 22% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.